Immunological Markers of Optimal Response to Natalizumab in Multiple Sclerosis
Archives of Neurology · 01.02.2012 · 69 (2) · 191
DOI: 10.1001/archneurol.2011.971 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archives of Neurology, erschienen am 01.02.2012. Verfasst von Luisa M Villar und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, Hospital Ramón y Cajal, Carretera de Colmenar Km 9.100, 28034 Madrid, Spain. lvillar.hrc@salud.madrid.org. Die Arbeit wurde bisher 50-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Immunology, Hospital Ramón y Cajal, Carretera de Colmenar Km 9.100, 28034 Madrid, Spain. lvillar.hrc@salud.madrid.org
Zitieren
APA
Villar, L. M., García-Sánchez, M. I., Costa-Frossard, L., Espiño, M., Roldán, E., Páramo, D., Lucas, M., Izquierdo, G., & Álvarez-Cermeño, J. C. (2012). Immunological Markers of Optimal Response to Natalizumab in Multiple Sclerosis. Archives of Neurology, 69(2), 191. https://doi.org/10.1001/archneurol.2011.971
Vancouver
Villar LM, García-Sánchez MI, Costa-Frossard L, Espiño M, Roldán E, Páramo D, et al. Immunological Markers of Optimal Response to Natalizumab in Multiple Sclerosis. Archives of Neurology. 2012;69(2):191. doi:10.1001/archneurol.2011.971
BibTeX
@article{Villar2012,
author = {Villar, Luisa M and García-Sánchez, María I and Costa-Frossard, Lucienne and Espiño, Mercedes and Roldán, Ernesto and Páramo, Dolores and Lucas, Miguel and Izquierdo, Guillermo and Álvarez-Cermeño, José C},
title = {Immunological Markers of Optimal Response to Natalizumab in Multiple Sclerosis},
journal = {Archives of Neurology},
year = {2012},
volume = {69},
number = {2},
pages = {191},
doi = {10.1001/archneurol.2011.971}
}
EUVIMED